Brady (BRC)
(Delayed Data from NYSE)
$71.81 USD
-1.38 (-1.89%)
Updated Sep 5, 2024 04:00 PM ET
Pre-Market: $76.00 +4.19 (5.83%) 9:26 AM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$71.81 USD
-1.38 (-1.89%)
Updated Sep 5, 2024 04:00 PM ET
Pre-Market: $76.00 +4.19 (5.83%) 9:26 AM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Zacks News
Brady (BRC) Q3 Earnings Top Estimates
by Zacks Equity Research
Brady (BRC) delivered earnings and revenue surprises of 14.04% and -1.38%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Brady (BRC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Brady (BRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aqua America (WTR) Catches Eye: Stock Jumps 6.7%
by Zacks Equity Research
Aqua America (WTR) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Emerson (EMR) Buys Bio-G to Boost Biomanufacturing Efficiency
by Zacks Equity Research
Emerson's (EMR) life sciences technology expertise combined with Bio-G's modeling & scheduling software solutions will aid biomanufacturing companies to optimize the production of patient therapies.
ABB Hit by Surging Costs and Business Integration Challenges
by Zacks Equity Research
Rising cost of sales on account of inflation in the prices of major inputs and high debt levels impede ABB's (ABB) growth.
iRobot Poised on Solid Demand in Key Markets Amid Risks
by Zacks Equity Research
Robust sales of Roomba e5 and Roomba i7 in the overseas end markets will drive iRobot's (IRBT) growth. However, the company faces stiff competition in U.S. robotic vacuum cleaning market.
Here's Why Brady (BRC) is a Suitable Investment Choice Now
by Zacks Equity Research
Brady (BRC) is likely to gain from product development, improvement in manufacturing facilities and focus on driving operational excellence. Investments to expand capacity are other tailwinds.
Strong Markets & Products Fuel TriMas Amid High Input Costs
by Zacks Equity Research
Continuous growth across TriMas' (TRS) key markets bodes well for its results.
Strong Markets & Products Fuel TriMas Amid High Input Costs
by Zacks Equity Research
Continuous growth across TriMas' (TRS) key markets bodes well for its results.
Emerson's (EMR) DeltaV Automation System Gets Certification
by Zacks Equity Research
Emerson's (EMR) receipt of latest certification for its DeltaV distributed control and safety systems confirms its adherence to cybersecurity requirements for process and safety controls.
Emerson Chosen by IndianOil for Modernization of Refineries
by Zacks Equity Research
Emerson's (EMR) multiple contracts with IndianOil will help the latter to modernize its operations and emissions programs at refineries.
Owens-Illinois Announces $60M Expansion Project in Europe
by Zacks Equity Research
Owens-Illinois (OI) plans to add capacity in Europe in order to cater to the rising demand of glass containers in the region.
Here's Why TriMas (TRS) Stock is Worth Investing in Right Now
by Zacks Equity Research
We suggest investors to retain TriMas (TRS) stock in their portfolio as it is poised to generate stellar returns.
RBC Bearings to Gain From Solid Demand in Markets Amid Risks
by Zacks Equity Research
Strong industrial original equipment manufacturers as well as mining, oil and gas, and machine tool demand are expected to boost RBC Bearings' (ROLL) growth. High cost of sales is a concern.
Here's Why You Should Hold on to Owens-Illinois Stock for Now
by Zacks Equity Research
We suggest investors to retain Owens-Illinois (OI) stock in their portfolio as it is poised to generate superior returns.
MRC Global (MRC) Displays Bright Prospects, Risks Persist
by Zacks Equity Research
Strong upstream business and solid demand for its product lines will strengthen MRC Global's (MRC) competency. However, weaker midstream sales might hurt near-term profitability.
Emerson (EMR) Unveils New Service Center in Permian Basin
by Zacks Equity Research
Emerson's (EMR) newly opened service center will cater to the increasing need for digital technologies for optimization of production efficiencies.
ABB Earnings & Revenues Miss Estimates in Q4, Orders Up Y/Y
by Zacks Equity Research
ABB's revenues rise year over year in Q4 courtesy of the Robotics and Motion segment's robust performance and the Electrification Products segment's solid momentum.
Brady (BRC) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Brady (BRC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Brady (BRC) Beats Q2 Earnings Estimates
by Zacks Equity Research
Brady (BRC) delivered earnings and revenue surprises of 3.77% and -1.38%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Allegion (ALLE) Q4 Earnings Beat Estimates, Revenues In Line
by Zacks Equity Research
Allegion's (ALLE) Q4 earnings jump year over year on the back of solid performance across all its segments.
What's in the Offing for Macquarie (MIC) in Q4 Earnings?
by Zacks Equity Research
Rising cost of sales and operating expenses, as well as weakness in the International-Matex Tank Terminals segment will weigh on Macquarie's (MIC) fourth-quarter results.
Brady (BRC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Brady (BRC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Brady (BRC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Brady (BRC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Brady (BRC) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Brady (BRC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.